REMIFENTANIL IN CRITICALLY ILL CARDIAC PATIENTS

Remifentanil has a unique pharmacokinetic profile, with a rapid onset and offset of action and a plasmatic metabolism.Its use can be recommended even in patients with renal impairment, hepatic dysfunction or poor cardiovascular function.A potential protective cardiac preconditioning effect has been suggested.Drug-related adverse effects seem to be